PRTA Stock Analysis: Buy, Sell, or Hold?
PRTA - Prothena Corporation plc Ordinary Shares
$8.20
-0.05 (-0.61%)
▼
5d:
-1.8%
30d:
-1.44%
90d:
-5.75%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 05, 2026
12d
Get Alerted When PRTA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: PRTA shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: PRTA shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: PRTA is currently trading at $8.20, which is considered oversold relative to its 30-day fair value range of $8.23 to $8.68. From a valuation perspective, the stock is trading at a discount (Forward PE: -6.2) compared to its historical average (18.0). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, PRTA is in a strong uptrend. Immediate support is located at $7.93, while resistance sits at $8.81.
Market Sentiment: PRTA scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $21.40 (+161.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PRTA is in a strong uptrend. Immediate support is located at $7.93, while resistance sits at $8.81.
Market Sentiment: PRTA scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $21.40 (+161.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$8.23 -
$8.68
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
69.2%
Protect Your Profits
Holding PRTA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 161.0% below Wall St target ($21.40)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Composite score 50/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$8.23 -
$8.68
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$0.69
(8.4%)
Support & Resistance Levels
Support Level
$7.93
Resistance Level
$8.81
Current Trend
Strong Uptrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.24
Wall Street Target
$21.40
(+161.0%)
Revenue Growth (YoY)
-77.1%
Profit Margin
-80.7%
PE vs Historical
-6.2 vs 18.0
CHEAP
Share & Embed Analysis
Last updated: October 23, 2026 6:41 PM ET
Data refreshes hourly during market hours. Next update: 7:41 PM
Data refreshes hourly during market hours. Next update: 7:41 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PRTA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
24 analysts |
$258 | 61 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$84 | 61 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 50 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$72 | 48 HOLD |
Advanced PRTA Option Strategies
Professional options setups generated by AI based on today's PRTA price and gamma walls.
